Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Successful and Safe Treatment of Intestinal Graft-Versus-Host Disease (GvHD) with Pooled-Donor Full Ecosystem Microbiota Biotherapeutics

Florent Malard, MD PhD, Faezeh Legrand, MD, Jérôme Cornillon, MD, Amandine Le Bourgeois, MD, Jean-Baptiste Mear, MD, Deborah Desmier, MD, Emilie Plantamura, PhD PharmD, Ronald Carter, MD MSc, MPH, Thierry Lamy De La Chapelle, MD PhD, Patrice Chevallier, MD, Denis Guyotat, MD PhD, Didier Blaise, MD PhD, Mohamad Mohty, MD PhD

Blood (2019) 134 (Supplement_1): 1993.

https://doi.org/10.1182/blood-2019-125540

Published: 2019

Journal Articles

Impact of Gut Mycobiota Composition on Outcomes after Allogeneic Hematopoietic Cell Transplantation

Florent Malard, MD PhD, Giorgia Battipaglia, MD, Béatrice Gaugler, PhD, Rémy Duléry, MD, Eolia Brissot, MD PhD, Tounes Ledraa, MD, Razan Mohty, MD, Harry Sokol, MD PhD, Mohamad Mohty, MD PhD

Blood (2019) 134 (Supplement_1): 194.

https://doi.org/10.1182/blood-2019-122256

Published: 2019

Journal Articles

Investigating Antibiotic Exposure and Risk of Severe Acute Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Razan Mohty, MD, Remy Dulery, MD, Giorgia Battipaglia, MD, Eolia Brissot, MD PhD, Clemence Mediavilla, MD, Simona Sestili, MD, Tounes Ledraa, MD, Béatrice Gaugler, PhD, Agnès Bonnin, Mohamad Mohty, MD PhD, Florent Malard, MD PhD

Blood (2019) 134 (Supplement_1): 4539.

https://doi.org/10.1182/blood-2019-125213

Published: 2019

Journal Articles

TEAM Conditioning (Thiotepa, Etoposide, Cytarabine, Melphalan) Prior to Autologous Hematopoietic Stem Cell Transplantation for Hodgkin and Non-Hodgkin Lymphoma: Final Results from a Prospective Multicenter Study

Rémy Duléry, MD, Laure Lebras, MD, Sylvain Choquet, MD, Roberta Di Blasi, Ahmad Kanj AL Jijakli, Laurence Heuberger, Eolia Brissot, MD PhD, Giorgia Battipaglia, MD, Florent Malard, MD PhD, Clemence Mediavilla, MD, Anne Vekhoff, MD, Paul Coppo, MD PhD, Tounes Ledraa, MD, Zora Marjanovic, Elise Corre, MD, Simona Lapusan, MD, Malek Aoudjhane, MD, Ramdane Belhocine, Mohamad Mohty, MD PhD

Blood (2019) 134 (Supplement_1): 786.

https://doi.org/10.1182/blood-2019-130651

Published: 2019

Journal Articles

A Delayed Innate T Cell Reconstitution Is Associated with Epstein-Barr Virus Reactivation after Haploidentical Hematopoietic Stem Cell Transplantation Using Anti-Thymoglobulin and High-Dose Post-Transplant Cyclophosphamide

Nicolas Stocker, MD, Agathe Farge, MD, Laure Ricard, MD, Vincent Jachiet, MD, Clemence Mediavilla, MD, Eolia Brissot, MD PhD, Giorgia Battipaglia, MD, Remy Duléry, MD, Simona Sestili, MD, Annalisa Ruggeri, MD, Razan Mohty, Mohamad Mohty, MD PhD, Béatrice Gaugler, PhD, Florent Malard, MD PhD

Blood (2018) 132 (Supplement 1): 3398.

https://doi.org/10.1182/blood-2018-99-111449

Published: 2018

Journal Articles

Hematopoietic Recovery and Transfusion Needs after Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Adult Patients with Hematologic Malignancies

Razan Mohty, Florent Malard, MD PhD, Annalisa Ruggeri, MD, Eolia Brissot, MD PhD, Remy Dulery, MD, Giorgia Battipaglia, MD, Frederica Giannotti, MD, Simona Sestili, MD, Clemence Mediavilla, MD, Mohamad Mohty, MD PhD

Blood (2018) 132 (Supplement 1): 2109.

https://doi.org/10.1182/blood-2018-99-119516

Published: 2018

Journal Articles

Extracorporeal Photopheresis for First Line Treatment of Acute Graft Versus Host Disease

Florent Malard, MD PhD, Simona Sestili, MD, Sandra Eder, MD, Ramdane Belhocine, Annalisa Ruggeri, MD, Giorgia Battipaglia, MD, Eolia Brissot, MD PhD, Clemence Mediavilla, MD, Remy Dulery, MD, Mohamad Mohty, MD PhD

Blood (2018) 132 (Supplement 1): 2114.

https://doi.org/10.1182/blood-2018-99-114544

Published: 2018

Journal Articles

Achievement of High Concentration of Cyclosporine-a Is Associated with a Low Incidence of Acute Graft-Versus-Host Disease after Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Graft

Nicolas Stocker, MD, Remy Duléry, MD, Clemence Mediavilla, MD, Eolia Brissot, MD PhD, Giorgia Battipaglia, MD, Simona Sestili, MD, Annalisa Ruggeri, MD, Razan Mohty, Mohamad Mohty, MD PhD, Florent Malard, MD PhD

Blood (2018) 132 (Supplement 1): 4565.

https://doi.org/10.1182/blood-2018-99-111406

Published: 2018

Journal Articles

Allogeneic Genetically Modified T Cells (HSV-TK) As Adjunctive Treatment in Haploidentical Hematopoietic Stem-Cell Transplantation (haplo-HSCT) of Adult Patients with High-Risk Hematological Malignancies: A Pair-Matched Analysis from the Acute Leukemia Working Party of EBMT

Mohamad Mohty, MD PhD, Myriam Labopin, MD, Andrea Velardi, MD, Maria Teresa van Lint, MD, Donald Bunjes, Benedetto Bruno, MD PhD, Stella Santarone, MD, Johanna Tischer, Yener Koc, MD, Depei Wu, MDPhD, Zafer Gulbas, MD, Annalisa Ruggeri, MD, Florent Malard, MD PhD, Simona Piemontese, MD, Maria Teresa Lupo Stanghellini, MD, Chiara Bonini, MD, Claudio Bordignon, MD, Fabio Ciceri, MD, Arnon Nagler

Blood (2016) 128 (22): 672.

https://doi.org/10.1182/blood.V128.22.672.672

Published: 2016

Journal Articles

CD34+ Selected Cells "Boost" for Poor Graft Function Post Allogeneic Stem Cell Transplantation

Razan Mohty, Annalisa Ruggeri, MD, Giorgia Battipaglia, MD, Florent Malard, MD PhD, Eolia Brissot, MD, Ramdane Belhocine, Sandra Eder, MD, Federica Giannotti, MD, Remy Dulery, MD, Mohamad Mohty, MD PhD

Blood (2016) 128 (22): 2300.

https://doi.org/10.1182/blood.V128.22.2300.2300

Published: 2016

Journal Articles

Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with High-Risk AML in Complete Remission: A Survey from the ALWP of the EBMT

Florent Malard, MD PhD, Myriam Labopin, MD, Gernot Stuhler, MD, Johanna Tischer, MD, Joerg Thomas Bittenbring, MD, Arnold Ganser, MD, Nicolaus Kroeger, MD, Donald Bunjes, MD, Christoph Schmid, MD, Jiri Mayer, Prof., MD, Mauricette Michallet, MD PhD, Michael Hallek, MD, Bipin N. Savani, MD, Mohamad Mohty, MD PhD, Arnon Nagler, MD MSc

Blood (2015) 126 (23): 3105.

https://doi.org/10.1182/blood.V126.23.3105.3105

Published: 2015

Journal Articles

Larger Number of Invariant Natural Killer T-Cells in Allogeneic Peripheral Blood Stem Cell Grafts Is Associated with Improved Graft-Versus-Host Disease-Free, Progression-Free Survival after Allogeneic Stem Cell Transplantation

Florent Malard, MD PhD, Myriam Labopin, MD, Patrice Chevallier, MD PhD, Thierry Guillaume, MD PhD, Alix Duquesne, Sophie Derenne, Eolia Brissot, MDPhD, Marc Gregoire, PhD, Philippe Moreau, Philippe Saas, PhD, Mohamad Mohty, MD PhD, Bbéatrice Gaugler, PhD

Blood (2015) 126 (23): 514.

https://doi.org/10.1182/blood.V126.23.514.514

Published: 2015

Journal Articles

Sequential Regimen of Clofarabine, Cytarabine and Reduced Intensity Conditioning (RIC) Prior to Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML) in Primary Treatment Failure

Mohamad Mohty, MD PhD, Florent Malard, MD PhD, Didier Blaise, MD, Noel Milpied, MD PhD, Gerard Socie, MD PhD, Anne Huynh, MD, Reman Oumedaly, Ibrahim Yakoub-Agha, MD PhD, Sabine Furst, MD, Thierry Guillaume, MD, Reza Tabrizi, MD, Jacques Delaunay, MD, Philippe Moreau, MD, Myriam Labopin, MD, Patrice Chevallier, MD PhD

Blood (2014) 124 (21): 1228.

https://doi.org/10.1182/blood.V124.21.1228.1228

Published: 2014

Journal Articles

Effect of Graft Source on Alternative Unrelated Donor Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation in Adults with Acute Myeloid Leukaemia after: A Study from the SFGM-TC

Florent Malard, MD PhD, Noel Milpied, MD PhD, Didier Blaise, MD, Patrice Chevallier, MD PhD, Mauricette Michallet, MD PhD, Bruno Lioure, MD PhD, Laurence Clement, Nathalie Fegueux, MD, Catherine Cordonnier, MD, Régis Peffault de Latour, MD, Mohamad Mohty, MD PhD

Blood (2014) 124 (21): 2541.

https://doi.org/10.1182/blood.V124.21.2541.2541

Published: 2014

NARROW

Successful and Safe Treatment of Intestinal Graft-Versus-Host Disease (GvHD) with Pooled-Donor Full Ecosystem Microbiota Biotherapeutics

Impact of Gut Mycobiota Composition on Outcomes after Allogeneic Hematopoietic Cell Transplantation

Investigating Antibiotic Exposure and Risk of Severe Acute Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

TEAM Conditioning (Thiotepa, Etoposide, Cytarabine, Melphalan) Prior to Autologous Hematopoietic Stem Cell Transplantation for Hodgkin and Non-Hodgkin Lymphoma: Final Results from a Prospective Multicenter Study

A Delayed Innate T Cell Reconstitution Is Associated with Epstein-Barr Virus Reactivation after Haploidentical Hematopoietic Stem Cell Transplantation Using Anti-Thymoglobulin and High-Dose Post-Transplant Cyclophosphamide

Hematopoietic Recovery and Transfusion Needs after Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Adult Patients with Hematologic Malignancies

Extracorporeal Photopheresis for First Line Treatment of Acute Graft Versus Host Disease

Achievement of High Concentration of Cyclosporine-a Is Associated with a Low Incidence of Acute Graft-Versus-Host Disease after Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Graft

Allogeneic Genetically Modified T Cells (HSV-TK) As Adjunctive Treatment in Haploidentical Hematopoietic Stem-Cell Transplantation (haplo-HSCT) of Adult Patients with High-Risk Hematological Malignancies: A Pair-Matched Analysis from the Acute Leukemia Working Party of EBMT

CD34+ Selected Cells "Boost" for Poor Graft Function Post Allogeneic Stem Cell Transplantation

Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with High-Risk AML in Complete Remission: A Survey from the ALWP of the EBMT

Larger Number of Invariant Natural Killer T-Cells in Allogeneic Peripheral Blood Stem Cell Grafts Is Associated with Improved Graft-Versus-Host Disease-Free, Progression-Free Survival after Allogeneic Stem Cell Transplantation

Sequential Regimen of Clofarabine, Cytarabine and Reduced Intensity Conditioning (RIC) Prior to Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML) in Primary Treatment Failure

Effect of Graft Source on Alternative Unrelated Donor Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation in Adults with Acute Myeloid Leukaemia after: A Study from the SFGM-TC

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only